Ono Pharmaceutical Co Ltd (4528) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB −0,07%	1 101,37	−0,81	−0,07%	—	1 102,18	1 096,24	1 103,05	1 090,35	—	—
SIXC Communications SIXC Communications	SIXC −0,47%	613,35	−2,89	−0,47%	—	616,24	616,24	617,68	609,10	—	—
SIXE Energy SIXE Energy	SIXE +0,77%	1 198,83	+9,11	+0,77%	—	1 189,72	1 194,74	1 202,79	1 188,58	—	—
SIXI Industrials SIXI Industrials	SIXI +1,75%	1 755,95	+30,26	+1,75%	—	1 725,69	1 730,02	1 762,99	1 730,02	—	—
SIXM Financials SIXM Financials	SIXM −0,79%	638,51	−5,11	−0,79%	—	643,62	643,13	643,17	632,59	—	—
SIXR Staples SIXR Staples	SIXR +1,65%	843,52	+13,73	+1,65%	—	829,79	832,32	845,25	832,32	—	—
SIXRE Real estate SIXRE Real estate	SIXRE +1,19%	215,95	+2,55	+1,19%	—	213,40	213,40	216,07	213,40	—	—
SIXT Technology SIXT Technology	SIXT −1,48%	3 138,91	−47,01	−1,48%	—	3 185,92	3 160,89	3 178,72	3 102,60	—	—
SIXU Utilities SIXU Utilities	SIXU +2,80%	934,37	+25,43	+2,80%	—	908,94	912,57	934,91	912,57	—	—
SIXV Health care SIXV Health care	SIXV −0,10%	1 477,43	−1,53	−0,10%	—	1 478,96	1 478,17	1 482,91	1 466,65	—	—
SIXY Discretionary SIXY Discretionary	SIXY −1,05%	2 380,19	−25,17	−1,05%	—	2 405,36	2 390,34	2 402,53	2 359,18	—	—

4528:TYO

Ono Pharmaceutical Co Ltd

2 316,00 JPY

−0,24%

(−5,50) 1 D

23. apr., 15:30:00 GMT+9 · JPY

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for 4528 …

Åpne

2 300 JPY

Høy

2 320 JPY

Lav

2 281 JPY

Markedsverdi

1,15 bill.

Snittvolum

1,93 mill.

Volum

1,77 mill.

Utbytte

3,45 %

Kvartalsvis utbytte

20 JPY

Første dato etter utbytte

29. sep. 2025

P/E-forhold

17,44

52 u høy

2 674 JPY

52 u lav

1 474 JPY

EPS

133 JPY

Utestående aksjer

514,12 mill.

Antall ansatte

Relaterte aksjer

Mitsubishi UFJ Financial Group Inc

Nyhetssaker

Fra kilder på nettet

Stock Titan

for 14 minutter siden

Alarm.com (NASDAQ: ALRM) details 2026 director elections, auditor and say-on-pay

Seeking Alpha

for 17 minutter siden

Stocks to watch on Thursday after hours: INTC, COUR, SAP (INTC:NASDAQ)

Yahoo Finance

for 22 minutter siden

SS&C (NASDAQ:SSNC) Beats Q1 CY2026 Sales Expectations

ChartMill

for 25 minutter siden

Gaming and Leisure Properties (NASDAQ:GLPI) Posts Record Q1 Earnings Beat, Raises Full-Year Guidance

Profil

Ono Pharmaceutical Co., Ltd. is one of the largest pharmaceutical companies in Japan. It is headquartered in Chuo-ku, Osaka, Japan, with its major plants in Higashinari-ku, Osaka, and Fujinomiya, Shizuoka., and its central research institute at Minase, Shimamoto-cho, Mishima District, Osaka. Ono Pharmaceutical's roots go back to 1717 when Ichibei Ono started his dealer business of pharmaceuticals in Osaka. His business expanded and changed its name a few times, and became Ono Pharmaceutical Industrial Co., Ltd. in 1948. Ono has been listed in Tokyo Stock Exchange since 1963. Its consolidated earnings in the half year ending in March 2018 were 16 billion Japanese yen. Nivolumab, the cancer drug based on the research of Prof. Dr. Tasuku Honjo of Kyoto University, who received the Nobel Prize later in 2018, is marketed by both Ono Pharmaceutical and Bristol-Myers Squibb. In 2024, Harvard University and Ono Pharmaceutical entered into a joint research and drug development agreement. Under it, promising projects to test therapeutic targets will be selected over 5 years under the guidance of Harvard's Office of Technology Development, and ONO will fund the work. Wikipedia

Om Ono Pharmaceutical Co Ltd

Administrerende direktørGyo Sagara

Ansatte4,29k

Grunnlagt1717

HovedkontorOsaka, Osaka, Japan

Sektor-

Nettstedono-pharma.com

Alle verdier i JPY	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	112,31 mrd.	127,54 mrd.	129,60 mrd.	139,90 mrd.
Varekostnad	45,24 mrd.	37,01 mrd.	34,96 mrd.	36,68 mrd.
Direkte driftskostnader	45,24 mrd.	37,01 mrd.	34,96 mrd.	36,68 mrd.
Utgifter til forskning og utvikling	46,30 mrd.	36,25 mrd.	34,77 mrd.	33,53 mrd.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	31,86 mrd.	31,09 mrd.	30,08 mrd.	31,73 mrd.
Driftskostnader	82,93 mrd.	68,53 mrd.	64,56 mrd.	67,00 mrd.
Totale driftskostnader	128,16 mrd.	105,54 mrd.	99,53 mrd.	103,68 mrd.
Driftsinntekter	−15,85 mrd.	22,00 mrd.	30,07 mrd.	36,22 mrd.
Andre ikke-operasjonelle inntekter	21,00 mill.	-	-	-
EBT inkludert uvanlige elementer	−12,71 mrd.	22,65 mrd.	29,52 mrd.	37,20 mrd.
EBT uten uvanlige elementer	−15,67 mrd.	22,65 mrd.	29,52 mrd.	37,20 mrd.
Kostnad for inntektsskatt	−6,34 mrd.	5,02 mrd.	7,17 mrd.	8,31 mrd.
Faktisk avgiftssats	49,90 %	22,16 %	24,30 %	22,35 %
Andre driftskostnader	1,31 mrd.	1,19 mrd.	−291,00 mill.	1,73 mrd.
Nettoinntekt	−6,54 mrd.	17,67 mrd.	22,42 mrd.	28,86 mrd.
Netto fortjenestemargin	−5,83 %	13,86 %	17,30 %	20,63 %
Resultat per aksje	-	-	-	-
Rente- og investeringsinntekter	1,90 mrd.	1,43 mrd.	677,00 mill.	1,39 mrd.
Rentekostnader	-	−773,00 mill.	−1,23 mrd.	−408,00 mill.
Netto rentekostnader	1,90 mrd.	655,00 mill.	−549,00 mill.	979,00 mill.
Avskrivnings- og amortiseringskostnader	3,45 mrd.	-	-	-
EBITDA	−7,13 mrd.	31,23 mrd.	39,39 mrd.	45,82 mrd.
Gevinst eller tap ved salg av eiendeler	7,98 mrd.	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning